Mary Redman, PhD
Professor
Clinical Research Division, Fred Hutch
Dr. Mary Redman is a biostatistician who specializes in complex studies, such as estimating the effects of treatments or environmental exposures that occur over many different points in time. She is especially interested in large-scale lung cancer treatment and prevention studies and works on them and other cancer trials as a statistician for SWOG, a National Cancer Institute–funded cooperative that conducts studies at 650 institutions across the U.S.
Other Appointments & Affiliations
Lead Statistician, Lung Cancer Committee, Southwest Oncology Group (SWOG)Lead Statistician
Lung Cancer Committee, Southwest Oncology Group (SWOG)
Lead Statistician
Lung-MAP
Education
PhD, Biostatistics, University of Washington, 2004
MS, Biostatistics, University of Washington, 2000
BS, Mathematics, University of Washington, 1997
Research Interests
Clinical trial design
Clinical trial design incorporating biomarkers